Farallon Capital Partners, L.P.

13D and 13G Filings

13D/G filings: 13D on 1 security, 13G on 23 securities
Location: San Francisco, CA
CIK: 0001175707
Form D filings: 17 filings
All SEC filings: View on sec.gov

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Schedule 13D · 1 security · may seek to influence control
Exelixis, Inc. 13D/A EXEL · 30161Q104	EXEL	30161Q104	5.9%	15,709,500	13D/A	1/5/2026 Event 1/1/2026
Farallon Capital Partners, L.P.			0.4%	1,189,334
Farallon Capital Institutional Partners, L.P.			0.5%	1,397,425
Farallon Capital Institutional Partners II, L.P.			0.1%	398,340
Farallon Capital Institutional Partners III, L.P.			0.1%	201,793
Four Crossings Institutional Partners V, L.P.			0.1%	263,099
Farallon Capital Offshore Investors II, L.P.			0.9%	2,487,976
Farallon Capital (AM) Investors, L.P.			0.1%	142,174
Farallon Capital F5 Master I, L.P.			0.2%	476,750
Farallon Healthcare Partners Master, L.P.			3.4%	9,152,609
Farallon Partners, L.L.C.			5.7%	15,232,750
Farallon Institutional (GP) V, L.L.C.			0.1%	263,099
Farallon F5 (GP), L.L.C.			0.2%	476,750
Farallon Healthcare Partners (GP), L.L.C.			3.4%	9,152,609
Dapice Joshua J.			5.9%	15,709,500
Dreyfuss, Philip D.			5.9%	15,709,500
Dunn Hannah E.			5.9%	15,709,500
Fried, Richard B			0%	0
Gehani, Varun N.			5.9%	15,709,500
Giauque, Nicolas			5.9%	15,709,500
Husen, Avner A.			5.9%	15,709,500
Kim, David T.			5.9%	15,709,500
Linn, Michael G.			5.9%	15,709,500
Luo Patrick (Cheng)			5.9%	15,709,500
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			5.9%	15,709,500
Saito Edric C.			5.9%	15,709,500
Seybold, William			0%	0
Short Daniel S.			5.9%	15,709,500
Spokes, Andrew J. M.			5.9%	15,709,500
Warren, John R.			5.9%	15,709,500
Wehrly, Mark C.			5.9%	15,709,500
Schedule 13G · 23 securities · passive
BridgeBio Pharma, Inc. 13G BBIO · 10806X102	BBIO	10806X102	5.2%	10,226,063	13G	5/29/2026 Event 5/22/2026
Farallon Capital Partners, L.P.			0.4%	728,238
Farallon Capital Institutional Partners, L.P.			0.5%	922,612
Farallon Capital Institutional Partners II, L.P.			0.1%	167,053
Farallon Capital Institutional Partners III, L.P.			0.1%	145,089
Four Crossings Institutional Partners V, L.P.			0.1%	171,156
Farallon Capital Offshore Investors II, L.P.			1.0%	1,869,577
Farallon Capital (AM) Investors, L.P.			0.1%	100,702
Farallon Capital F5 Master I, L.P.			0.1%	202,722
Farallon Healthcare Partners Master, L.P.			3.0%	5,918,914
Farallon Partners, L.L.C.			5.1%	10,023,341
Farallon Institutional (GP) V, L.L.C.			0.1%	171,156
Farallon F5 (GP), L.L.C.			0.1%	202,722
Farallon Healthcare Partners (GP), L.L.C.			3.0%	5,918,914
Dapice Joshua J.			5.2%	10,226,063
Dreyfuss, Philip D.			5.2%	10,226,063
Dunn Hannah E.			5.2%	10,226,063
Gehani, Varun N.			5.2%	10,226,063
Giauque, Nicolas			5.2%	10,226,063
Husen, Avner A.			5.2%	10,226,063
Kim, David T.			5.2%	10,226,063
Linn, Michael G.			5.2%	10,226,063
Luo Patrick (Cheng)			5.2%	10,226,063
Roberts, Jr., Thomas G.			5.2%	10,226,063
Saito Edric C.			5.2%	10,226,063
Short Daniel S.			5.2%	10,226,063
Spokes, Andrew J. M.			5.2%	10,226,063
Warren, John R.			5.2%	10,226,063
Wehrly, Mark C.			5.2%	10,226,063
InflaRx N.V. 13G IFRX · N44821101	IFRX	N44821101	5.1%	7,500,000	13G	5/14/2026 Event 5/7/2026
Farallon Capital Partners, L.P.			0.8%	1,206,750
Farallon Capital Institutional Partners, L.P.			1.3%	1,882,500
Farallon Capital Institutional Partners II, L.P.			0.1%	99,000
Farallon Capital Institutional Partners III, L.P.			0.2%	304,500
Four Crossings Institutional Partners V, L.P.			0.2%	359,250
Farallon Capital Offshore Investors II, L.P.			2.3%	3,380,250
Farallon Capital (AM) Investors, L.P.			0.1%	75,000
Farallon Capital F5 Master I, L.P.			0.1%	192,750
Farallon Partners, L.L.C.			5.0%	7,307,250
Farallon Institutional (GP) V, L.L.C.			0.2%	359,250
Farallon F5 (GP), L.L.C.			0.1%	192,750
Dapice Joshua J.			5.1%	7,500,000
Dreyfuss, Philip D.			5.1%	7,500,000
Dunn Hannah E.			5.1%	7,500,000
Gehani, Varun N.			5.1%	7,500,000
Giauque, Nicolas			5.1%	7,500,000
Husen, Avner A.			5.1%	7,500,000
Kim, David T.			5.1%	7,500,000
Linn, Michael G.			5.1%	7,500,000
Luo Patrick (Cheng)			5.1%	7,500,000
Roberts, Jr., Thomas G.			5.1%	7,500,000
Saito Edric C.			5.1%	7,500,000
Short Daniel S.			5.1%	7,500,000
Spokes, Andrew J. M.			5.1%	7,500,000
Warren, John R.			5.1%	7,500,000
Wehrly, Mark C.			5.1%	7,500,000
Tyra Biosciences, Inc. 13G/A TYRA · 90240B106	TYRA	90240B106	6.6%	3,580,818	13G/A	5/12/2026 Event 3/31/2026
Farallon Capital Partners, L.P.			1.1%	579,376
Farallon Capital Institutional Partners, L.P.			1.4%	739,107
Farallon Capital Institutional Partners II, L.P.			0.2%	121,341
Farallon Capital Institutional Partners III, L.P.			0.2%	105,941
Four Crossings Institutional Partners V, L.P.			0.2%	126,343
Farallon Capital Offshore Investors II, L.P.			2.7%	1,452,596
Farallon Capital (AM) Investors, L.P.			0.1%	74,008
Farallon Capital F5 Master I, L.P.			0.3%	173,106
Farallon Healthcare Partners Master, L.P.			0.4%	209,000
Farallon Partners, L.L.C.			6.3%	3,407,712
Farallon Institutional (GP) V, L.L.C.			0.2%	126,343
Farallon F5 (GP), L.L.C.			0.3%	173,106
Farallon Healthcare Partners (GP), L.L.C.			0.4%	209,000
Dapice Joshua J.			6.6%	3,580,818
Dreyfuss, Philip D.			6.6%	3,580,818
Dunn Hannah E.			6.6%	3,580,818
Gehani, Varun N.			6.6%	3,580,818
Giauque, Nicolas			6.6%	3,580,818
Husen, Avner A.			6.6%	3,580,818
Kim, David T.			6.6%	3,580,818
Linn, Michael G.			6.6%	3,580,818
Luo Patrick (Cheng)			6.6%	3,580,818
Roberts, Jr., Thomas G.			6.6%	3,580,818
Saito Edric C.			6.6%	3,580,818
Short Daniel S.			6.6%	3,580,818
Spokes, Andrew J. M.			6.6%	3,580,818
Warren, John R.			6.6%	3,580,818
Wehrly, Mark C.			6.6%	3,580,818
Beta Bionics, Inc. 13G/A BBNX · 08659B102	BBNX	08659B102	8.1%	3,607,920	13G/A	5/12/2026 Event 3/31/2026
Zone Healthcare Holdings, LLC			5.8%	2,560,220
Farallon Capital Partners, L.P.			0.4%	188,360
Farallon Capital Institutional Partners, L.P.			0.4%	197,381
Farallon Capital Institutional Partners II, L.P.			0.1%	63,438
Farallon Capital Institutional Partners III, L.P.			0.1%	48,629
Four Crossings Institutional Partners V, L.P.			0.1%	44,541
Farallon Capital Offshore Investors II, L.P.			1.0%	436,671
Farallon Capital (AM) Investors, L.P.			0.1%	28,440
Farallon Capital F5 Master I, L.P.			0.1%	40,240
Farallon Capital Management, L.L.C.			5.8%	2,560,220
Farallon Partners, L.L.C.			2.3%	1,007,460
Farallon F5 (GP), L.L.C.			0.1%	40,240
Farallon Institutional (GP) V, L.L.C.			0.1%	44,541
Dapice Joshua J.			8.1%	3,607,920
Dreyfuss, Philip D.			8.1%	3,607,920
Dunn Hannah E.			8.1%	3,607,920
Gehani, Varun N.			8.1%	3,607,920
Giauque, Nicolas			8.1%	3,607,920
Husen, Avner A.			8.1%	3,607,920
Kim, David T.			8.1%	3,607,920
Linn, Michael G.			8.1%	3,607,920
Luo Patrick (Cheng)			8.1%	3,607,920
Roberts, Jr., Thomas G.			8.1%	3,607,920
Saito Edric C.			8.1%	3,607,920
Short Daniel S.			8.1%	3,607,920
Spokes, Andrew J. M.			8.1%	3,607,920
Warren, John R.			8.1%	3,607,920
Wehrly, Mark C.			8.1%	3,607,920
GRAIL, Inc. 13G/A GRAL · 384747101	GRAL	384747101	7.8%	3,253,684	13G/A	5/11/2026 Event 3/31/2026
Farallon Capital Partners, L.P.			0.6%	249,315
Farallon Capital Institutional Partners, L.P.			0.7%	267,221
Farallon Capital Institutional Partners II, L.P.			0.2%	67,446
Farallon Capital Institutional Partners III, L.P.			0.1%	50,555
Four Crossings Institutional Partners V, L.P.			0.1%	57,183
Farallon Capital Offshore Investors II, L.P.			1.5%	595,840
Farallon Capital (AM) Investors, L.P.			0.1%	34,045
Farallon Capital F5 Master I, L.P.			0.2%	67,660
Farallon Healthcare Partners Master, L.P.			4.5%	1,864,419
Farallon Partners, L.L.C.			7.7%	3,186,024
Farallon Institutional (GP) V, L.L.C.			0.1%	57,183
Farallon F5 (GP), L.L.C.			0.2%	67,660
Farallon Healthcare Partners (GP), L.L.C.			4.5%	1,864,419
Dapice Joshua J.			7.8%	3,253,684
Dreyfuss, Philip D.			7.8%	3,253,684
Dunn Hannah E.			7.8%	3,253,684
Gehani, Varun N.			7.8%	3,253,684
Giauque, Nicolas			7.8%	3,253,684
Husen, Avner A.			7.8%	3,253,684
Kim, David T.			7.8%	3,253,684
Linn, Michael G.			7.8%	3,253,684
Luo Patrick (Cheng)			7.8%	3,253,684
Roberts, Jr., Thomas G.			7.8%	3,253,684
Saito Edric C.			7.8%	3,253,684
Short Daniel S.			7.8%	3,253,684
Spokes, Andrew J. M.			7.8%	3,253,684
Warren, John R.			7.8%	3,253,684
Wehrly, Mark C.			7.8%	3,253,684
Tango Therapeutics, Inc. 13G/A TNGX · 87583X109	TNGX	87583X109	7.8%	11,257,203	13G/A	5/11/2026 Event 3/31/2026
Farallon Capital Partners, L.P.			0.7%	1,055,717
Farallon Capital Institutional Partners, L.P.			1.0%	1,470,591
Farallon Capital Institutional Partners II, L.P.			0.2%	290,563
Farallon Capital Institutional Partners III, L.P.			0.2%	226,033
Four Crossings Institutional Partners V, L.P.			0.2%	260,503
Farallon Capital Offshore Investors II, L.P.			1.7%	2,488,434
Farallon Capital (AM) Investors, L.P.			0.1%	163,734
Farallon Capital F5 Master I, L.P.			0.2%	292,726
Farallon Healthcare Partners Master, L.P.			3.5%	5,008,902
Farallon Partners, L.L.C.			7.6%	10,964,477
Farallon Institutional (GP) V, L.L.C.			0.2%	260,503
Farallon F5 (GP), L.L.C.			0.2%	292,726
Farallon Healthcare Partners (GP), L.L.C.			3.5%	5,008,902
Dapice Joshua J.			7.8%	11,257,203
Dreyfuss, Philip D.			7.8%	11,257,203
Dunn Hannah E.			7.8%	11,257,203
Gehani, Varun N.			7.8%	11,257,203
Giauque, Nicolas			7.8%	11,257,203
Husen, Avner A.			7.8%	11,257,203
Kim, David T.			7.8%	11,257,203
Linn, Michael G.			7.8%	11,257,203
Luo Patrick (Cheng)			7.8%	11,257,203
Roberts, Jr., Thomas G.			7.8%	11,257,203
Saito Edric C.			7.8%	11,257,203
Short Daniel S.			7.8%	11,257,203
Spokes, Andrew J. M.			7.8%	11,257,203
Warren, John R.			7.8%	11,257,203
Wehrly, Mark C.			7.8%	11,257,203
Liquidia Corporation 13G/A LQDA · 53635D202	LQDA	53635D202	9.9%	8,656,038	13G/A	2/9/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			0.8%	691,175
Farallon Capital Institutional Partners, L.P.			0.7%	631,454
Farallon Capital Institutional Partners II, L.P.			0.3%	260,734
Farallon Capital Institutional Partners III, L.P.			0.2%	157,353
Four Crossings Institutional Partners V, L.P.			0.2%	162,456
Farallon Capital Offshore Investors II, L.P.			1.8%	1,530,567
Farallon Capital F5 Master I, L.P.			0.2%	187,044
Farallon Capital (AM) Investors, L.P.			0.1%	100,979
Farallon Healthcare Partners Master, L.P.			5.7%	4,934,276
Farallon Partners, L.L.C.			9.7%	8,468,994
Farallon Institutional (GP) V, L.L.C.			0.2%	162,456
Farallon F5 (GP), L.L.C.			0.2%	187,044
Farallon Healthcare Partners (GP), L.L.C.			5.7%	4,934,276
Dapice Joshua J.			9.9%	8,656,038
Dreyfuss, Philip D.			9.9%	8,656,038
Dunn Hannah E.			9.9%	8,656,038
Fried, Richard B			0%	0
Gehani, Varun N.			9.9%	8,656,038
Giauque, Nicolas			9.9%	8,656,038
Husen, Avner A.			9.9%	8,656,038
Kim, David T.			9.9%	8,656,038
Linn, Michael G.			9.9%	8,656,038
Luo Patrick (Cheng)			9.9%	8,656,038
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			9.9%	8,656,038
Saito Edric C.			9.9%	8,656,038
Seybold, William			0%	0
Short Daniel S.			9.9%	8,656,038
Spokes, Andrew J. M.			9.9%	8,656,038
Warren, John R.			9.9%	8,656,038
Wehrly, Mark C.			9.9%	8,656,038
Agios Pharmaceuticals, Inc. 13G/A AGIO · 00847X104	AGIO	00847X104	8.8%	5,159,505	13G/A	2/9/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			0.7%	413,359
Farallon Capital Institutional Partners, L.P.			0.8%	446,450
Farallon Capital Institutional Partners II, L.P.			0.2%	136,781
Farallon Capital Institutional Partners III, L.P.			0.1%	56,489
Four Crossings Institutional Partners V, L.P.			0.2%	97,883
Farallon Capital Offshore Investors II, L.P.			1.6%	904,525
Farallon Capital (AM) Investors, L.P.			0.1%	62,455
Farallon Capital F5 Master I, L.P.			0.2%	113,104
Farallon Healthcare Partners Master, L.P.			5.0%	2,928,459
Farallon Partners, L.L.C.			8.7%	5,046,401
Farallon Institutional (GP) V, L.L.C.			0.2%	97,883
Farallon F5 (GP), L.L.C.			0.2%	113,104
Farallon Healthcare Partners (GP), L.L.C.			5.0%	2,928,459
Dapice Joshua J.			8.8%	5,159,505
Dreyfuss, Philip D.			8.8%	5,159,505
Dunn Hannah E.			8.8%	5,159,505
Fried, Richard B			0%	0
Gehani, Varun N.			8.8%	5,159,505
Giauque, Nicolas			8.8%	5,159,505
Husen, Avner A.			8.8%	5,159,505
Kim, David T.			8.8%	5,159,505
Linn, Michael G.			8.8%	5,159,505
Luo Patrick (Cheng)			8.8%	5,159,505
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			8.8%	5,159,505
Saito Edric C.			8.8%	5,159,505
Seybold, William			0%	0
Short Daniel S.			8.8%	5,159,505
Spokes, Andrew J. M.			8.8%	5,159,505
Warren, John R.			8.8%	5,159,505
Wehrly, Mark C.			8.8%	5,159,505
Revolution Medicines, Inc. 13G/A RVMD · 76155X100	RVMD	76155X100	7.5%	14,596,149	13G/A	2/9/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			0.5%	1,057,562
Farallon Capital Institutional Partners, L.P.			0.7%	1,377,579
Farallon Capital Institutional Partners II, L.P.			0.2%	332,755
Farallon Capital Institutional Partners III, L.P.			0.1%	164,197
Four Crossings Institutional Partners V, L.P.			0.1%	238,987
Farallon Capital Offshore Investors II, L.P.			1.3%	2,482,796
Farallon Capital (AM) Investors, L.P.			0.1%	151,742
Farallon Capital F5 Master I, L.P.			0.2%	370,466
Farallon Healthcare Partners Master, L.P.			4.4%	8,420,065
Farallon Partners, L.L.C.			7.4%	14,225,683
Farallon Institutional (GP) V, L.L.C.			0.1%	238,987
Farallon F5 (GP), L.L.C.			0.2%	370,466
Farallon Healthcare Partners (GP), L.L.C.			4.4%	8,420,065
Dapice Joshua J.			7.5%	14,596,149
Dreyfuss, Philip D.			7.5%	14,596,149
Dunn Hannah E.			7.5%	14,596,149
Fried, Richard B			0%	0
Gehani, Varun N.			7.5%	14,596,149
Giauque, Nicolas			7.5%	14,596,149
Husen, Avner A.			7.5%	14,596,149
Kim, David T.			7.5%	14,596,149
Linn, Michael G.			7.5%	14,596,149
Luo Patrick (Cheng)			7.5%	14,596,149
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			7.5%	14,596,149
Saito Edric C.			7.5%	14,596,149
Seybold, William			0%	0
Short Daniel S.			7.5%	14,596,149
Spokes, Andrew J. M.			7.5%	14,596,149
Warren, John R.			7.5%	14,596,149
Wehrly, Mark C.			7.5%	14,596,149
Assembly Biosciences, Inc. 13G/A ASMB · 045396207	ASMB	045396207	7.8%	1,227,590	13G/A	2/9/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			1.5%	239,462
Farallon Capital Institutional Partners, L.P.			1.4%	224,245
Farallon Capital Institutional Partners II, L.P.			0.5%	75,077
Farallon Capital Institutional Partners III, L.P.			0.3%	48,548
Four Crossings Institutional Partners V, L.P.			0.4%	58,135
Farallon Capital Offshore Investors II, L.P.			3.1%	497,192
Farallon Capital (AM) Investors, L.P.			0.2%	32,933
Farallon Capital F5 Master I, L.P.			0.3%	51,998
Farallon Partners, L.L.C.			7.4%	1,175,592
Farallon Institutional (GP) V, L.L.C.			0.4%	58,135
Farallon F5 (GP), L.L.C.			0.3%	51,998
Dapice Joshua J.			7.8%	1,227,590
Dreyfuss, Philip D.			7.8%	1,227,590
Dunn Hannah E.			7.8%	1,227,590
Fried, Richard B			0%	0
Gehani, Varun N.			7.8%	1,227,590
Giauque, Nicolas			7.8%	1,227,590
Husen, Avner A.			7.8%	1,227,590
Kim, David T.			7.8%	1,227,590
Linn, Michael G.			7.8%	1,227,590
Luo Patrick (Cheng)			7.8%	1,227,590
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			7.8%	1,227,590
Saito Edric C.			7.8%	1,227,590
Seybold, William			0%	0
Short Daniel S.			7.8%	1,227,590
Spokes, Andrew J. M.			7.8%	1,227,590
Warren, John R.			7.8%	1,227,590
Wehrly, Mark C.			7.8%	1,227,590
Protagonist Therapeutics, Inc. 13G/A PTGX · 74366E102	PTGX	74366E102	10.0%	6,248,013	13G/A	2/6/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			0.5%	283,062
Farallon Capital Institutional Partners, L.P.			0.5%	290,850
Farallon Capital Institutional Partners II, L.P.			0.1%	91,421
Farallon Capital Institutional Partners III, L.P.			0.1%	39,417
Four Crossings Institutional Partners V, L.P.			0.1%	53,343
Farallon Capital Offshore Investors II, L.P.			0.9%	565,080
Farallon Capital (AM) Investors, L.P.			0.1%	36,181
Farallon Capital F5 Master I, L.P.			0.2%	121,094
Farallon Healthcare Partners Master, L.P.			7.6%	4,767,564
Farallon Partners, L.L.C.			9.8%	6,126,919
Farallon Institutional (GP) V, L.L.C.			0.1%	53,343
Farallon F5 (GP), L.L.C.			0.2%	121,094
Farallon Healthcare Partners (GP), L.L.C.			7.6%	4,767,564
Dapice Joshua J.			10.0%	6,248,013
Dreyfuss, Philip D.			10.0%	6,248,013
Dunn Hannah E.			10.0%	6,248,013
Fried, Richard B			0%	0
Gehani, Varun N.			10.0%	6,248,013
Giauque, Nicolas			10.0%	6,248,013
Husen, Avner A.			10.0%	6,248,013
Kim, David T.			10.0%	6,248,013
Linn, Michael G.			10.0%	6,248,013
Luo Patrick (Cheng)			10.0%	6,248,013
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			10.0%	6,248,013
Saito Edric C.			10.0%	6,248,013
Seybold, William			0%	0
Short Daniel S.			10.0%	6,248,013
Spokes, Andrew J. M.			10.0%	6,248,013
Warren, John R.			10.0%	6,248,013
Wehrly, Mark C.			10.0%	6,248,013
Lantheus Holdings, Inc. 13G/A CATX · 46489V104	CATX	46489V104	8.2%	5,427,479	13G/A	2/5/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			0.6%	420,581
Farallon Capital Institutional Partners, L.P.			0.7%	495,662
Farallon Capital Institutional Partners II, L.P.			0.2%	99,754
Farallon Capital Institutional Partners III, L.P.			0.1%	58,265
Four Crossings Institutional Partners V, L.P.			0.1%	88,798
Farallon Capital Offshore Investors II, L.P.			1.5%	968,900
Farallon Capital (AM) Investors, L.P.			0.1%	60,808
Farallon Capital F5 Master I, L.P.			0.2%	145,543
Farallon Healthcare Partners Master, L.P.			4.7%	3,089,168
Farallon Partners, L.L.C.			8.0%	5,281,936
Farallon Institutional (GP) V, L.L.C.			0.1%	88,798
Farallon F5 (GP), L.L.C.			0.2%	145,543
Farallon Healthcare Partners (GP), L.L.C.			4.7%	3,089,168
Dapice Joshua J.			8.2%	5,427,479
Dreyfuss, Philip D.			8.2%	5,427,479
Dunn Hannah E.			8.2%	5,427,479
Fried, Richard B			0%	0
Gehani, Varun N.			8.2%	5,427,479
Giauque, Nicolas			8.2%	5,427,479
Husen, Avner A.			8.2%	5,427,479
Kim, David T.			8.2%	5,427,479
Linn, Michael G.			8.2%	5,427,479
Luo Patrick (Cheng)			8.2%	5,427,479
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			8.2%	5,427,479
Saito Edric C.			8.2%	5,427,479
Seybold, William			0%	0
Short Daniel S.			8.2%	5,427,479
Spokes, Andrew J. M.			8.2%	5,427,479
Warren, John R.			8.2%	5,427,479
Wehrly, Mark C.			8.2%	5,427,479
Beam Therapeutics Inc. 13G/A BEAM · 07373V105	BEAM	07373V105	10.0%	10,141,856	13G/A	2/5/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			0.7%	688,623
Farallon Capital Institutional Partners, L.P.			0.8%	836,691
Farallon Capital Institutional Partners II, L.P.			0.2%	233,233
Farallon Capital Institutional Partners III, L.P.			0.1%	104,266
Four Crossings Institutional Partners V, L.P.			0.1%	150,101
Farallon Capital Offshore Investors II, L.P.			1.6%	1,632,718
Farallon Capital (AM) Investors, L.P.			0.1%	94,237
Farallon Capital F5 Master I, L.P.			0.3%	333,253
Farallon Healthcare Partners Master, L.P.			6.0%	6,068,735
Farallon Partners, L.L.C.			9.7%	9,808,603
Farallon Institutional (GP) V, L.L.C.			0.1%	150,101
Farallon F5 (GP), L.L.C.			0.3%	333,253
Farallon Healthcare Partners (GP), L.L.C.			6.0%	6,068,735
Dapice Joshua J.			10.0%	10,141,856
Dreyfuss, Philip D.			10.0%	10,141,856
Dunn Hannah E.			10.0%	10,141,856
Fried, Richard B			0%	0
Gehani, Varun N.			10.0%	10,141,856
Giauque, Nicolas			10.0%	10,141,856
Husen, Avner A.			10.0%	10,141,856
Kim, David T.			10.0%	10,141,856
Linn, Michael G.			10.0%	10,141,856
Luo Patrick (Cheng)			10.0%	10,141,856
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			10.0%	10,141,856
Saito Edric C.			10.0%	10,141,856
Seybold, William			0%	0
Short Daniel S.			10.0%	10,141,856
Spokes, Andrew J. M.			10.0%	10,141,856
Warren, John R.			10.0%	10,141,856
Wehrly, Mark C.			10.0%	10,141,856
Savara Inc. 13G/A SVRA · 805111101	SVRA	805111101	6.9%	15,000,000	13G/A	2/5/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			1.2%	2,488,500
Farallon Capital Institutional Partners, L.P.			1.9%	3,843,000
Farallon Capital Institutional Partners II, L.P.			0.4%	804,000
Farallon Capital Institutional Partners III, L.P.			0.2%	492,000
Four Crossings Institutional Partners V, L.P.			0.3%	543,000
Farallon Capital Offshore Investors II, L.P.			2.7%	5,659,500
Farallon Capital (AM) Investors, L.P.			0.1%	204,000
Farallon Capital F5 Master I, L.P.			0.5%	966,000
Farallon Partners, L.L.C.			6.5%	14,034,000
Farallon Institutional (GP) V, L.L.C.			0.3%	543,000
Farallon F5 (GP), L.L.C.			0.5%	966,000
Dapice Joshua J.			6.9%	15,000,000
Dreyfuss, Philip D.			6.9%	15,000,000
Dunn Hannah E.			6.9%	15,000,000
Fried, Richard B			0%	0
Gehani, Varun N.			6.9%	15,000,000
Giauque, Nicolas			6.9%	15,000,000
Husen, Avner A.			6.9%	15,000,000
Kim, David T.			6.9%	15,000,000
Linn, Michael G.			6.9%	15,000,000
Luo Patrick (Cheng)			6.9%	15,000,000
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			6.9%	15,000,000
Saito Edric C.			6.9%	15,000,000
Seybold, William			0%	0
Short Daniel S.			6.9%	15,000,000
Spokes, Andrew J. M.			6.9%	15,000,000
Warren, John R.			6.9%	15,000,000
Wehrly, Mark C.			6.9%	15,000,000
Minerva Neurosciences, Inc. 13G/A NERV · 603380205	NERV	603380205	10.0%	4,539,854	13G/A	2/5/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			2.0%	870,793
Farallon Capital Institutional Partners, L.P.			1.9%	828,223
Farallon Capital Institutional Partners II, L.P.			0.6%	259,677
Farallon Capital Institutional Partners III, L.P.			0.4%	168,861
Four Crossings Institutional Partners V, L.P.			0.5%	213,323
Farallon Capital Offshore Investors II, L.P.			4.2%	1,856,998
Farallon Capital (AM) Investors, L.P.			0.3%	118,723
Farallon Capital F5 Master I, L.P.			0.5%	223,256
Farallon Partners, L.L.C.			9.5%	4,316,598
Farallon Institutional (GP) V, L.L.C.			0.5%	213,323
Farallon F5 (GP), L.L.C.			0.5%	223,256
Dapice Joshua J.			10.0%	4,539,854
Dreyfuss, Philip D.			10.0%	4,539,854
Dunn Hannah E.			10.0%	4,539,854
Fried, Richard B			0%	0
Gehani, Varun N.			10.0%	4,539,854
Giauque, Nicolas			10.0%	4,539,854
Husen, Avner A.			10.0%	4,539,854
Kim, David T.			10.0%	4,539,854
Linn, Michael G.			10.0%	4,539,854
Luo Patrick (Cheng)			10.0%	4,539,854
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			10.0%	4,539,854
Saito Edric C.			10.0%	4,539,854
Seybold, William			0%	0
Short Daniel S.			10.0%	4,539,854
Spokes, Andrew J. M.			10.0%	4,539,854
Warren, John R.			10.0%	4,539,854
Wehrly, Mark C.			10.0%	4,539,854
Enanta Pharmaceuticals, Inc. 13G/A ENTA · 29251M106	ENTA	29251M106	9.8%	2,816,862	13G/A	2/5/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			1.8%	531,119
Farallon Capital Institutional Partners, L.P.			2.1%	595,851
Farallon Capital Institutional Partners II, L.P.			0.5%	150,355
Farallon Capital Institutional Partners III, L.P.			0.3%	84,528
Four Crossings Institutional Partners V, L.P.			0.4%	108,002
Farallon Capital Offshore Investors II, L.P.			3.8%	1,110,733
Farallon Capital (AM) Investors, L.P.			0.2%	60,191
Farallon Capital F5 Master I, L.P.			0.6%	176,083
Farallon Partners, L.L.C.			9.1%	2,640,779
Farallon Institutional (GP) V, L.L.C.			0.4%	108,002
Farallon F5 (GP), L.L.C.			0.6%	176,083
Dapice Joshua J.			9.8%	2,816,862
Dreyfuss, Philip D.			9.8%	2,816,862
Dunn Hannah E.			9.8%	2,816,862
Fried, Richard B			0%	0
Gehani, Varun N.			9.8%	2,816,862
Giauque, Nicolas			9.8%	2,816,862
Husen, Avner A.			9.8%	2,816,862
Kim, David T.			9.8%	2,816,862
Linn, Michael G.			9.8%	2,816,862
Luo Patrick (Cheng)			9.8%	2,816,862
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			9.8%	2,816,862
Saito Edric C.			9.8%	2,816,862
Seybold, William			0%	0
Short Daniel S.			9.8%	2,816,862
Spokes, Andrew J. M.			9.8%	2,816,862
Warren, John R.			9.8%	2,816,862
Wehrly, Mark C.			9.8%	2,816,862
Crinetics Pharmaceuticals, Inc. 13G/A CRNX · 22663K107	CRNX	22663K107	8.5%	8,024,098	13G/A	2/5/2026 Event 12/31/2025
Farallon Capital Partners, L.P.			0.6%	584,527
Farallon Capital Institutional Partners, L.P.			0.7%	709,270
Farallon Capital Institutional Partners II, L.P.			0.2%	168,850
Farallon Capital Institutional Partners III, L.P.			0.1%	103,335
Four Crossings Institutional Partners V, L.P.			0.1%	135,338
Farallon Capital Offshore Investors II, L.P.			1.4%	1,369,733
Farallon Capital (AM) Investors, L.P.			0.1%	72,967
Farallon Capital F5 Master I, L.P.			0.2%	197,760
Farallon Healthcare Partners Master, L.P.			4.9%	4,682,318
Farallon Partners, L.L.C.			8.2%	7,826,338
Farallon Institutional (GP) V, L.L.C.			0.1%	135,338
Farallon F5 (GP), L.L.C.			0.2%	197,760
Farallon Healthcare Partners (GP), L.L.C.			4.9%	4,682,318
Dapice Joshua J.			8.5%	8,024,098
Dreyfuss, Philip D.			8.5%	8,024,098
Dunn Hannah E.			8.5%	8,024,098
Fried, Richard B			0%	0
Gehani, Varun N.			8.5%	8,024,098
Giauque, Nicolas			8.5%	8,024,098
Husen, Avner A.			8.5%	8,024,098
Kim, David T.			8.5%	8,024,098
Linn, Michael G.			8.5%	8,024,098
Luo Patrick (Cheng)			8.5%	8,024,098
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			8.5%	8,024,098
Saito Edric C.			8.5%	8,024,098
Seybold, William			0%	0
Short Daniel S.			8.5%	8,024,098
Spokes, Andrew J. M.			8.5%	8,024,098
Warren, John R.			8.5%	8,024,098
Wehrly, Mark C.			8.5%	8,024,098
The New York Times Company 13G/A NYT · 650111107	NYT	650111107	3.5%	5,609,546	13G/A	8/12/2025 Event 6/30/2025
Farallon Capital Partners, L.P.			0.2%	276,190
Farallon Capital Institutional Partners, L.P.			0.2%	366,655
Farallon Capital Institutional Partners II, L.P.			0.1%	87,527
Farallon Capital Institutional Partners III, L.P.			0%	54,091
Four Crossings Institutional Partners V, L.P.			0%	71,367
Farallon Capital Offshore Investors II, L.P.			0.4%	661,749
Farallon Capital (AM) Investors, L.P.			0%	36,446
Farallon Capital F5 Master I, L.P.			0.1%	133,525
Farallon Equity Partners Master, L.P.			2.4%	3,921,996
Farallon Partners, L.L.C.			3.4%	5,476,021
Farallon Institutional (GP) V, L.L.C.			0%	71,367
Farallon F5 (GP), L.L.C.			0.1%	133,525
Farallon Equity Partners (GP), L.L.C.			2.4%	3,921,996
Dapice Joshua J.			3.5%	5,609,546
Dreyfuss, Philip D.			3.5%	5,609,546
Dunn Hannah E.			3.5%	5,609,546
Fried, Richard B			3.5%	5,609,546
Gehani, Varun N.			3.5%	5,609,546
Giauque, Nicolas			3.5%	5,609,546
Kim, David T.			3.5%	5,609,546
Linn, Michael G.			3.5%	5,609,546
Luo Patrick (Cheng)			3.5%	5,609,546
Patel, Rajiv A.			3.5%	5,609,546
Roberts, Jr., Thomas G.			3.5%	5,609,546
Saito Edric C.			3.5%	5,609,546
Seybold, William			3.5%	5,609,546
Short Daniel S.			3.5%	5,609,546
Spokes, Andrew J. M.			3.5%	5,609,546
Warren, John R.			3.5%	5,609,546
Wehrly, Mark C.			3.5%	5,609,546
Aramark 13G/A ARMK · 03852U106	ARMK	03852U106	4.9%	12,899,701	13G/A	8/12/2025 Event 6/30/2025
Farallon Capital Partners, L.P.			0.3%	670,717
Farallon Capital Institutional Partners, L.P.			0.3%	808,378
Farallon Capital Institutional Partners II, L.P.			0.1%	168,227
Farallon Capital Institutional Partners III, L.P.			0%	102,282
Four Crossings Institutional Partners V, L.P.			0.1%	140,860
Farallon Capital Offshore Investors II, L.P.			0.6%	1,590,986
Farallon Capital (AM) Investors, L.P.			0%	95,267
Farallon Capital F5 Master I, L.P.			0.1%	252,061
Farallon Equity Partners Master, L.P.			3.5%	9,070,923
Farallon Partners, L.L.C.			4.8%	12,647,640
Farallon Institutional (GP) V, L.L.C.			0.1%	140,860
Farallon F5 (GP), L.L.C.			0.1%	252,061
Farallon Equity Partners (GP), L.L.C.			3.5%	9,070,923
Dapice Joshua J.			4.9%	12,899,701
Dreyfuss, Philip D.			4.9%	12,899,701
Dunn Hannah E.			4.9%	12,899,701
Fried, Richard B			4.9%	12,899,701
Gehani, Varun N.			4.9%	12,899,701
Giauque, Nicolas			4.9%	12,899,701
Kim, David T.			4.9%	12,899,701
Linn, Michael G.			4.9%	12,899,701
Luo Patrick (Cheng)			4.9%	12,899,701
Patel, Rajiv A.			4.9%	12,899,701
Roberts, Jr., Thomas G.			4.9%	12,899,701
Saito Edric C.			4.9%	12,899,701
Seybold, William			4.9%	12,899,701
Short Daniel S.			4.9%	12,899,701
Spokes, Andrew J. M.			4.9%	12,899,701
Warren, John R.			4.9%	12,899,701
Wehrly, Mark C.			4.9%	12,899,701
23andMe Holding Co. 13G MEHCQ · 90138Q306	MEHCQ	90138Q306	6.2%	1,270,908	13G	6/20/2025 Event 6/13/2025
Farallon Capital Partners, L.P.			1.1%	221,858
Farallon Capital Institutional Partners, L.P.			1.0%	195,040
Farallon Capital Institutional Partners II, L.P.			0.5%	107,337
Farallon Capital Institutional Partners III, L.P.			0.3%	67,533
Four Crossings Institutional Partners V, L.P.			0.3%	70,155
Farallon Capital Offshore Investors II, L.P.			2.6%	525,633
Farallon Capital F5 Master I, L.P.			0.2%	39,667
Farallon Capital (AM) Investors, L.P.			0.2%	43,685
Farallon Partners, L.L.C.			6.0%	1,231,241
Farallon Institutional (GP) V, L.L.C.			0.3%	70,155
Farallon F5 (GP), L.L.C.			0.2%	39,667
Dapice Joshua J.			6.2%	1,270,908
Dreyfuss, Philip D.			6.2%	1,270,908
Dunn Hannah E.			6.2%	1,270,908
Fried, Richard B			6.2%	1,270,908
Gehani, Varun N.			6.2%	1,270,908
Giauque, Nicolas			6.2%	1,270,908
Kim, David T.			6.2%	1,270,908
Linn, Michael G.			6.2%	1,270,908
Luo Patrick (Cheng)			6.2%	1,270,908
Patel, Rajiv A.			6.2%	1,270,908
Roberts, Jr., Thomas G.			6.2%	1,270,908
Saito Edric C.			6.2%	1,270,908
Seybold, William			6.2%	1,270,908
Short Daniel S.			6.2%	1,270,908
Spokes, Andrew J. M.			6.2%	1,270,908
Warren, John R.			6.2%	1,270,908
Wehrly, Mark C.			6.2%	1,270,908
Elevation Oncology, Inc. 13G/A ELEV · 28623U101	ELEV	28623U101	0%	0	13G/A	5/7/2025 Event 3/31/2025
Farallon Capital Partners, L.P.			0%	0
Farallon Capital Institutional Partners, L.P.			0%	0
Farallon Capital Institutional Partners II, L.P.			0%	0
Farallon Capital Institutional Partners III, L.P.			0%	0
Four Crossings Institutional Partners V, L.P.			0%	0
Farallon Capital Offshore Investors II, L.P.			0%	0
Farallon Capital F5 Master I, L.P.			0%	0
Farallon Capital (AM) Investors, L.P.			0%	0
Farallon Partners, L.L.C.			0%	0
Farallon Institutional (GP) V, L.L.C.			0%	0
Farallon F5 (GP), L.L.C.			0%	0
Dapice Joshua J.			0%	0
Dreyfuss, Philip D.			0%	0
Dunn Hannah E.			0%	0
Fried, Richard B			0%	0
Gehani, Varun N.			0%	0
Giauque, Nicolas			0%	0
Kim, David T.			0%	0
Linn, Michael G.			0%	0
Luo Patrick (Cheng)			0%	0
Patel, Rajiv A.			0%	0
Roberts, Jr., Thomas G.			0%	0
Saito Edric C.			0%	0
Seybold, William			0%	0
Short Daniel S.			0%	0
Spokes, Andrew J. M.			0%	0
Warren, John R.			0%	0
Wehrly, Mark C.			0%	0
AleAnna, Inc. 13G/A ANNA · 01444V103	ANNA	01444V103	2.6%	1,068,400	13G/A	2/10/2025 Event 12/31/2024
Farallon Capital Partners, L.P.			0.4%	148,823
Farallon Capital Institutional Partners, L.P.			0.5%	221,817
Farallon Capital Institutional Partners II, L.P.			0.1%	50,822
Farallon Capital Institutional Partners III, L.P.			0.1%	29,360
Four Crossings Institutional Partners V, L.P.			0.1%	35,839
Farallon Capital Offshore Investors II, L.P.			1.1%	441,406
Farallon Capital (AM) Investors, L.P.			0%	14,275
Farallon Capital F5 Master I, L.P.			0.2%	70,058
Farallon Capital Management, L.L.C.			0.1%	56,000
Farallon Partners, L.L.C.			2.3%	942,342
Farallon Institutional (GP) V, L.L.C.			0.1%	35,839
Farallon F5 (GP), L.L.C.			0.2%	70,058
Dapice Joshua J.			2.6%	1,068,400
Dreyfuss, Philip D.			2.6%	1,068,400
Dunn Hannah E.			2.6%	1,068,400
Fried, Richard B			2.6%	1,068,400
Gehani, Varun N.			2.6%	1,068,400
Giauque, Nicolas			2.6%	1,068,400
Kim, David T.			2.6%	1,068,400
Linn, Michael G.			2.6%	1,068,400
Luo Patrick (Cheng)			2.6%	1,068,400
Patel, Rajiv A.			2.6%	1,068,400
Roberts, Jr., Thomas G.			2.6%	1,068,400
Saito Edric C.			2.6%	1,068,400
Seybold, William			2.6%	1,068,400
Short Daniel S.			2.6%	1,068,400
Spokes, Andrew J. M.			2.6%	1,068,400
Warren, John R.			2.6%	1,068,400
Wehrly, Mark C.			2.6%	1,068,400
Forte Biosciences, Inc. 13G/A FBRX · 34962G109	FBRX	34962G109	3.4%	221,027	13G/A	2/10/2025 Event 12/31/2024
Farallon Capital Partners, L.P.			0.6%	36,759
Farallon Capital Institutional Partners, L.P.			0.8%	49,579
Farallon Capital Institutional Partners II, L.P.			0.2%	14,682
Farallon Capital Institutional Partners III, L.P.			0.1%	5,922
Four Crossings Institutional Partners V, L.P.			0.1%	6,646
Farallon Capital Offshore Investors II, L.P.			1.3%	84,073
Farallon Capital (AM) Investors, L.P.			0.1%	5,565
Farallon Capital F5 Master I, L.P.			0.3%	17,801
Farallon Partners, L.L.C.			3.1%	203,226
Farallon Institutional (GP) V, L.L.C.			0.1%	6,646
Farallon F5 (GP), L.L.C.			0.3%	17,801
Dapice Joshua J.			3.4%	221,027
Dreyfuss, Philip D.			3.4%	221,027
Dunn Hannah E.			3.4%	221,027
Fried, Richard B			3.4%	221,027
Gehani, Varun N.			3.4%	221,027
Giauque, Nicolas			3.4%	221,027
Kim, David T.			3.4%	221,027
Linn, Michael G.			3.4%	221,027
Luo Patrick (Cheng)			3.4%	221,027
Patel, Rajiv A.			3.4%	221,027
Roberts, Jr., Thomas G.			3.4%	221,027
Saito Edric C.			3.4%	221,027
Seybold, William			3.4%	221,027
Short Daniel S.			3.4%	221,027
Spokes, Andrew J. M.			3.4%	221,027
Warren, John R.			3.4%	221,027
Wehrly, Mark C.			3.4%	221,027

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.